Symptoms and Endoscopic Results in Consideration of Pretreatment

AstraZeneca

Status: Completed

Conditions: Gastrointestinal Diseases

Study type: Observational

Funder types: Industry

Identifiers

NCT00612404

1312004008

Details and patient eligibility

About

Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. gastroenterologists) are asked to document relevant data in patients with gastrointestinal disorders.

Enrollment: 16,255 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with gastrointestinal disorders who need an endoscopy.

Exclusion criteria

• limitiations; possible risks; warnings; contraindications mentioned in the SPC.

Trial design

16,255 participants in 1 patient group

1

Description:

patients with gastrointestinal disorders who need an endoscopy.